Issue 21, 2022
From the journal:

Nanoscale Advances

Correction: CTL–doxorubicin (DOX)–gold complex nanoparticles (DOX–AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model

Qiqian Liu,ae   Hui Liu,be   Pasquale Sacco,ce   Nadia Djaker,ae   Marc Lamy de la Chapelle,de   Eleonora Marsich,ce   Xiaowu Li*be  and  Jolanda Spadavecchia*ae  

* Corresponding authors

a CNRS, UMR 7244, NBD-CSPBAT, Laboratoire de Chimie, Structures et Propriétés de Biomatériaux et d’Agents Thérapeutiques Université Paris 13, Sorbonne Paris Nord, Bobigny, France
E-mail: jolanda.spadavecchia@univ-paris13.fr

b Department of Hepato-biliary Surgery, Shenzhen University General Hospital, Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Carson International Cancer, Shenzhen, China

c Department of Life Sciences, University of Trieste, Via L. Giorgieri 5, I-34127 Trieste, Italy

d Department of Medicine, Surgery and Health Sciences, University of Trieste, Piazzale Europa 1, I-34127 Trieste, Italy

e IMMM – UMR 6283 CNRS, Université du Mans, Avenue Olivier Messiaen, 72085 Le Mans, Cedex 9, France

Abstract

Correction for ‘CTL–doxorubicin (DOX)–gold complex nanoparticles (DOX–AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model’ by Qiqian Liu et al., Nanoscale Adv., 2020, 2, 5231–5241. https://doi.org/10.1039/D0NA00758G.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D2NA90075K
Article type
Correction
Submitted
14 Sep 2022
Accepted
14 Sep 2022
First published
14 Oct 2022
This article is Open Access
Creative Commons BY license

Nanoscale Adv., 2022,4, 4701-4702

Permissions

Request permissions

Correction: CTL–doxorubicin (DOX)–gold complex nanoparticles (DOX–AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model

Q. Liu, H. Liu, P. Sacco, N. Djaker, M. Lamy de la Chapelle, E. Marsich, X. Li and J. Spadavecchia, Nanoscale Adv., 2022, 4, 4701 DOI: 10.1039/D2NA90075K

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements